Kindred Bio: Q4 Earnings Snapshot
March 16, 2021
FacebookTwitterEmail
BURLINGAME, Calif. (AP) Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $10.9 million in its fourth quarter.
The Burlingame, California-based company said it had a loss of 28 cents per share.
The biopharmaceutical company posted revenue of $951,000 in the period.
For the year, the company reported that its loss narrowed to $21.8 million, or 55 cents per share. Revenue was reported as $42.2 million.
In the final minutes of trading on Tuesday, the company s shares hit $4.94. A year ago, they were trading at $6.01.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN
Kindred Biosciences (NASDAQ:KIN), (ELAN) - Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.